Bank of New York Mellon
ESMC

Bank of New York Mellon’s Escalon Medical Corp ESMC Stock Holding History

Bank of New York Mellon’s Portfolio ESMC Stock Details ESMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-16,000
Closed -$11K – 4367
2016
Q3 		$11K Hold
16,000
– – ﹤0.01% 4244
2016
Q2 		$12K Hold
16,000
– – ﹤0.01% 4288
2016
Q1 		$13K Hold
16,000
– – ﹤0.01% 4185
2015
Q4 		$17K Hold
16,000
– – ﹤0.01% 4286
2015
Q3 		$19K Hold
16,000
– – ﹤0.01% 4323
2015
Q2 		$23K Hold
16,000
– – ﹤0.01% 4215
2015
Q1 		$22K Hold
16,000
– – ﹤0.01% 4193
2014
Q4 		$26K Hold
16,000
– – ﹤0.01% 4199
2014
Q3 		$24K Hold
16,000
– – ﹤0.01% 4196
2014
Q2 		$27K Hold
16,000
– – ﹤0.01% 4117
2014
Q1 		$24K Hold
16,000
– – ﹤0.01% 4141
2013
Q4 		$32K Buy
+16,000
New +$25.9K ﹤0.01% 4148

Other funds holding ESMC

WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Bank of New York Mellon's ESMC Position: Q4 2016 in Review

Bank of New York Mellon sold out of Escalon Medical Corp (ESMC) in Q4 2016, closing a stake of 16,000 shares — an estimated $11K sold.

Bank of New York Mellon first reported a position in ESMC in Q4 2013 and held it in 12 quarters. The position peaked at $32K in Q4 2013. 3 funds tracked by Wall St. Rank hold ESMC as of Q4 2016.

  • Bank of New York Mellon reported no remaining Escalon Medical Corp position as of Q4 2016 after selling out during the quarter.
  • Bank of New York Mellon sold 16,000 Escalon Medical Corp shares in Q4 2016, an estimated $11K.
  • Bank of New York Mellon first reported a position in Escalon Medical Corp in Q4 2013 and held it in 12 quarters.
  • Bank of New York Mellon's Escalon Medical Corp position peaked at $32K in Q4 2013.
  • 3 funds tracked by Wall St. Rank held Escalon Medical Corp as of Q4 2016.

Based on Bank of New York Mellon's 13F filing for Q4 2016, filed 13 Feb 2017.